• Explore /
  • Poster
  • / Maintenance therapy with olaparib or selumetinib plus durvalumab (S+D) according to genetic profile of metastatic pancreatic adenocarcinoma (m-PDAC) controlled with modified FOLFIRINOX (mFFX): A phase II randomized MAZEPPA GERCOR D19-02 PRODIGE-72 study.

Maintenance therapy with olaparib or selumetinib plus durvalumab (S+D) according to genetic profile of metastatic pancreatic adenocarcinoma (m-PDAC) controlled with modified FOLFIRINOX (mFFX): A phase II randomized MAZEPPA GERCOR D19-02 PRODIGE-72 study.

Abstract Poster

Authors

Pascal Hammel

Pascal Hammel

Paris-Saclay University, Digestive and Medical Oncology Department, Paul Brousse Hospital, APHP, Villejuif, France

Pascal Hammel , Meher Ben Abdelghani , Gael Roth , Ayhan Ulusakarya , François Ghiringhelli , Clemence Toullec , Christophe Borg , Olivia Hentic Dhome , Isabelle Trouilloud , Laetitia Dahan , Sandrine Hiret , Olivier Bouche , Yves Rinaldi , Jean-Frédéric Blanc , Christelle De La Fouchardiere , Cindy Neuzillet , Maud Kamal , Antoine Falcoz , Anthony Turpin , Rosine Guimbaud

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04348045

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 673)

DOI

10.1200/JCO.2024.42.3_suppl.673

Abstract #

673

Poster Bd #

M2

Abstract Disclosures

Similar Posters

First Author: Vincent Chung

First Author: Vaibhav Sahai

First Author: B.J. Rimel

First Author: Michael Sangmin Lee